{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:39Z","timestamp":1786120299389,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/inf.0b013e31825384ae","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T06:02:36Z","timestamp":1331877756000},"page":"705-710","source":"Crossref","is-referenced-by-count":47,"title":["Bacteremic Pneumococcal Community-acquired Pneumonia in Children Less Than 5 Years of Age in Italy"],"prefix":"10.1097","volume":"31","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto E.","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liviana Da","family":"Dalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pelucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Schito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-3099(01)00170-0","article-title":"Estimates of world-wide distribution of child deaths from acute respiratory infections.","volume":"2","author":"Williams","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R3-9-20210202","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1469-0691.2011.03526.x","article-title":"Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989-2008).","volume":"17","author":"Esteva","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 3","key":"R5-9-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.","volume":"15","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/CVI.00383-10","article-title":"Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine.","volume":"18","author":"Ansaldi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R7-9-20210202","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.vaccine.2010.12.114","article-title":"Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid.","volume":"29","author":"Picazo","year":"2011","journal-title":"Vaccine"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/INF.0b013e3181c2a229","article-title":"Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.","volume":"29","author":"Techasaensiri","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/11202760-000000000-00000","article-title":"Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).","volume":"11","author":"Croxtall","year":"2009","journal-title":"Paediatr Drugs"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"PCV13 Infant Study Group. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"R11-9-20210202","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R12-9-20210202","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R14-9-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","article-title":"Simultaneous detection of Neisseria meningitidis Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.","volume":"39","author":"Corless","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R15-9-20210202","doi-asserted-by":"crossref","first-page":"e9282","DOI":"10.1371\/journal.pone.0009282","article-title":"Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease.","volume":"5","author":"Azzari","year":"2010","journal-title":"PLoS One"},{"key":"R16-9-20210202","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/656579","article-title":"Italian Group for the Study of Invasive Pneumococcal Disease. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples.","volume":"51","author":"Resti","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R19-9-20210202","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1183\/09031936.00099807","article-title":"Necrotising pneumonia is an increasingly detected complication of pneumonia in children.","volume":"31","author":"Sawicki","year":"2008","journal-title":"Eur Respir J"},{"issue":"Pt 3","key":"R20-9-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1099\/jmm.0.05460-0","article-title":"Autolysin-targeted LightCycler assay including internal process control for detection of Streptococcus pneumoniae DNA in clinical samples.","volume":"53","author":"Sheppard","year":"2004","journal-title":"J Med Microbiol"},{"key":"R21-9-20210202","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1469-0691.2008.02028.x","article-title":"Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR.","volume":"14","author":"Tarrago","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R22-9-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1574-6968.2010.02044.x","article-title":"Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae.","volume":"310","author":"Park","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"R23-9-20210202","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/JCM.42.5.1863-1868.2004","article-title":"Practical considerations in design of internal amplification controls for diagnostic PCR assays.","volume":"42","author":"Hoorfar","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R24-9-20210202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/mdr.2011.0031","article-title":"Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children 5 years of age with community-acquired pneumonia.","volume":"17","author":"Marchese","year":"2011","journal-title":"Microb Drug Resist"},{"key":"R25-9-20210202","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/656580","article-title":"Expanding the diagnosis of pediatric bacteremic pneumococcal pneumonia from blood cultures to molecular methods: advantages and caveats.","volume":"51","author":"Ramirez","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Pt 6","key":"R26-9-20210202","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1099\/jmm.0.028357-0","article-title":"Pneumococcal DNA is not detectable in the blood of healthy carrier children by real-time PCR targeting the lytA gene.","volume":"60","author":"Azzari","year":"2011","journal-title":"J Med Microbiol"},{"key":"R27-9-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archpedi.157.4.389","article-title":"Risk of bacteremia in young children with pneumonia treated as outpatients.","volume":"157","author":"Shah","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R28-9-20210202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"R29-9-20210202","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.clinthera.2009.06.010","article-title":"Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection.","volume":"31","author":"Resti","year":"2009","journal-title":"Clin Ther"},{"key":"R30-9-20210202","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/thx.2003.016105","article-title":"Clinical features, aetiology and outcome of empyema in children in the north east of England.","volume":"59","author":"Eastham","year":"2004","journal-title":"Thorax"},{"key":"R31-9-20210202","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/344191","article-title":"Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia.","volume":"35","author":"Esposito","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R32-9-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3181c15471","article-title":"Massachusetts Department of Public Health. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.","volume":"29","author":"Hsu","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R34-9-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/erv.10.145","article-title":"Global prevailing and emerging pediatric pneumococcal serotypes.","volume":"10","author":"McIntosh","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R35-9-20210202","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/JCM.01827-10","article-title":"Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.","volume":"49","author":"Yu","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R36-9-20210202","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/S0264-410X(03)00110-5","article-title":"Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.","volume":"21","author":"Esposito","year":"2003","journal-title":"Vaccine"},{"key":"R37-9-20210202","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.vaccine.2004.09.029","article-title":"Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants.","volume":"23","author":"Esposito","year":"2005","journal-title":"Vaccine"},{"key":"R38-9-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/INF.0b013e3181cffa2a","article-title":"Effectiveness of pneumococcal conjugate vaccine using a 21 infant schedule in Quebec, Canada.","volume":"29","author":"Deceuninck","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R39-9-20210202","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 21 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31825384ae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:42:06Z","timestamp":1786048926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201207000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31825384ae","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}